ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™
September 11, 2019 08:00 ET
|
ImmuCell Corporation
PORTLAND, Maine, Sept. 11, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) – a growing animal health company that develops, manufactures and markets...
ImmuCell Receives FDA Response To First CMC Submission for Re-Tain™
August 29, 2019 08:00 ET
|
ImmuCell Corporation
Second Submission Anticipated Around Q3 2020 PORTLAND, Maine, Aug. 29, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) – a growing animal health company...
ImmuCell Announces Unaudited Financial Results for Second Quarter of 2019
August 12, 2019 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 12, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) – a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019
August 06, 2019 08:00 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 06, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) - a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for First Quarter of 2019
May 13, 2019 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, May 13, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) – a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019
May 07, 2019 09:00 ET
|
ImmuCell Corporation
PORTLAND, Maine, May 07, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) - a growing animal health company that develops, manufactures and markets...
ImmuCell Corporation Announces Closing of $9 Million Public Offering of Common Stock
March 29, 2019 11:45 ET
|
ImmuCell Corporation
PORTLAND, Maine, March 29, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Corporation Announces Pricing of $9.0 Million Public Offering of Common Stock
March 27, 2019 07:30 ET
|
ImmuCell Corporation
PORTLAND, Maine, March 27, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Corporation Announces Commencement of Public Offering of Common Stock
March 26, 2019 16:10 ET
|
ImmuCell Corporation
PORTLAND, Maine, March 26, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Submission of Manufacturing Technical Section for its Purified Nisin Product
February 28, 2019 14:00 ET
|
ImmuCell Corporation
PORTLAND, Maine, Feb. 28, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...